1031P Tilsotolimod engages the TLR9 pathway to promote antigen presentation and type I IFN signaling in solid tumours
- Resource Type
- Abstract
- Authors
- Babiker, H.; Borazanci, E.; Subbiah, V.; Algazi, A.P.; Schachter, J.; Lotem, M.; Hendler, D.; Rahimian, S.; Minderman, H.; Haymaker, C.; Bernatchez, C.; Murthy, R.; Hultsch, R.; Caplan, N.; Woodhead, G.J.; Hennemeyer, C.T.; Chunduru, S.; Anderson, P.; Diab, A.; Puzanov, I.
- Source
- In Annals of Oncology September 2020 31 Supplement 4:S711-S712
- Subject
- Language
- ISSN
- 0923-7534